PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20942814-0	2011	Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFbeta1 expression and activation of p38-MAPK and ERK1/2.	scutellarin	0-11	mitogen activated protein kinase 14	Rattus norvegicus	137-140	
31792810-4	2020	Furthermore, expression of p-p38 along with that of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta(IL-1beta), and inducible nitric oxide synthase (iNOS) in LPS-activated microglia subjected to pretreatment with p38 inhibitor SB203580, p38 activator sc-201214, scutellarin, or a combination of them was evaluated.	scutellarin	273-284	mitogen activated protein kinase 14	Rattus norvegicus	29-32	
31792810-5	2020	FINDINGS: Scutellarin markedly attenuated the expression of p-p38, p-JNK in AM/BM in MCAO rats and in vitro.	scutellarin	10-21	mitogen activated protein kinase 14	Rattus norvegicus	62-65	
31792810-11	2020	CONCLUSIONS: The results suggest that scutellarin down-regulates the expression of proinflammatory mediators in AM/BM through suppressing the p-JNK and p-p38 MAPKs.	scutellarin	38-49	mitogen activated protein kinase 14	Rattus norvegicus	154-157	
31792810-13	2020	Besides, p38 MAPKs activator reverses the effect of scutellarin.	scutellarin	52-63	mitogen activated protein kinase 14	Rattus norvegicus	9-12	
18442013-6	2007	These results demonstrate that scutellarin can protect PC12 cells from cobalt chloride induced apoptosis by scavenging ROS, inhibiting p38 phosphorylation, up-regulating Bcl-XL expression and decreasing caspase-3 activity, and may reduce the cellular damage in pathological conditions associated with hypoxia-mediated neuronal injury.	scutellarin	31-42	mitogen activated protein kinase 14	Rattus norvegicus	135-138